Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)

Listen Now

Topics Covered

• Overview of Triple Negative Breast Cancer, in the Context of COVID-19
• New Research on TNBC Presented at the San Antonio Breast Cancer Symposium (SABCS)
• Triple Negative Breast Cancer-Specific Treatment Updates
• Updates on Clinical Trials in Advancing Treatment Choices
• The Increasing Role of Diagnostic Testing, Biomarkers & Genetic Testing in Informing Treatment Options
• Investigational New Therapies in Clinical Trials
• New Developments in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort & Pain
• Communicating with the Health Care Team with Telehealth/Telemedicine Appointments
• Guidelines to prepare for Telehealth/Telemedicine Appointments, including Technology, List of Questions, Adherence, Follow-Up Care & Discussion of OpenNotes
• Key Questions to Ask Your Health Care Team
• Questions for our Panel of Experts

Our Panel of Experts

Virginia Kaklamani, MD, DSc

Professor of Medicine, Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment, A.B. Alexander Distinguished Chair in Oncology, Leader, Breast Oncology Program, UT Health San Antonio, MD Anderson Cancer Center

Minetta C. Liu, MD

Professor and Research Chair, Division of Medical Oncology, Department of Oncology, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Medical Director, Office of Specialty Collaborations and Contracts, Co-Leader, Genomics in Action Strategic Priority, Center for Individualized Medicine, Mayo Clinic

Kamel Abou Hussein, MD

Lead Physician, Breast Medical Oncology, MD Anderson at Cooper Cancer Center

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation^®

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on December 21, 2021.